.png){kind=icon}
返回
Utilizing graph machine learning within drug discovery and development
.png){kind=icon}
OA
AI
DOI：10.1093/bib/bbab159.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Graph machine learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst other data types. Herein, we present a multidisciplinary academic-industrial review of the topic within the context of drug discovery and development. After introducing key terms and modelling approaches, we move chronologically through the drug development pipeline to identify and summarize work incorporating: target identification, design of small molecules and biologics, and drug repurposing. Whilst the field is still emerging, key milestones including repurposed drugs entering in vivo studies, suggest GML will become a modelling framework of choice within biomedical machine learning.
Keyword:
graph machine learning
drug discovery
drug development
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.7
论文数:
5.8K
被引数:
2.7W
机构
暂无机构信息
引用论文
The Drug Repurposing Hub: a next-generation drug library and information resource.png)
NATURE MEDICINEOAAI
NATURE MEDICINEIF50
OAAI分享收藏Reduction of ischemic spinal cord injury by dextrorphan: Comparison of several methods of administrationDexorphan减少缺血性脊髓损伤: 几种给药方法的比较OAAI
OAAI分享收藏BioGRID: a general repository for interaction datasetsBioGRID: 交互数据集的通用存储库NUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAI分享收藏分享收藏分享收藏
查看更多内容